There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open2,565
High2,578.6
Low2,528.1
Prev. Close2,556.9
Avg. Traded Price2,552.59
Volume23,220
MARKET DEPTH
Total bid13,639.00
Total ask14,503.00
Orders
Qty
Bid
1
1
2562.2
1
1
2561.7
1
8
2561.6
2
22
2561.5
2
17
2561.4
Ask
Qty
Orders
2563.1
2
2
2563.7
1
1
2563.8
1
1
2563.9
2
5
2564
2
9
HIGH/LOW
1d
1w
1m
3m
52w
LOW/HIGH
₹2,528.1027 minutes ago
₹2,578.6027 minutes ago
LOWER/UPPER CIRCUITS
₹2,045.60
₹3,068.20
Mankind Pharma Limited Stock performance
KEY OBSERVATIONS
positive
negative
neutral
Annual Revenue,rose 19.57%, in the last year to ₹10,615.63 Cr. Its sector's average revenue growth for the last fiscal year was 12.27%.
Annual Net Profit,rose 49.23% in the last year to ₹1,912.9 Cr. Its sector's average net profit growth for the last fiscal year was 29.44%.
Return on Equity(ROE),for the last financial year was 20.43%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.
Mankind Pharma Limited is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices, and has an established track record of building and scaling brands in-house. It has created many brands in its pharmaceutical business.
Grow your wealth with more research recommendations